What is Longevity Science? A Clear-Headed Beginner's Guide
Reviewed by the BioAgeIQ Editorial Team · Last reviewed June 2026
Longevity science is the study of aging — why it happens, how to slow it, and eventually how to reverse it. It's moved from fringe science to mainstream research in the last decade, with billions in funding, Nobel Prize-winning discoveries, and practical interventions you can use today.
✓ Pros
- Rapidly advancing field with serious academic and commercial investment
- Multiple interventions with strong human evidence available now
- Increasingly accessible through wearables and consumer testing
- Clear framework (hallmarks of aging) for understanding the field
✗ Cons
- Much promising research is still in animal models
- Media hype often outruns the evidence
- Some interventions require medical supervision
- The field moves faster than regulatory frameworks
| Category | Details |
|---|---|
| Key researchers | David Sinclair, Peter Attia, Aubrey de Grey, Morgan Levine |
| Key institutions | Harvard, Salk Institute, Buck Institute, Calico |
| Key journals | Nature Aging, Cell, Aging Cell |
| Main framework | The 12 Hallmarks of Aging (Lopez-Otin et al.) |
| Best book | Lifespan (Sinclair) or Outlive (Attia) |
| Most studied interventions | Caloric restriction, exercise, rapamycin, metformin |
| Available consumer interventions | Exercise, diet, sleep, supplements, wearables, epigenetic testing |
What Longevity Science Actually Studies
Longevity science asks: why do organisms age, and what can we do about it? This spans multiple disciplines — molecular biology, genetics, epigenetics, metabolism, immunology — and is increasingly driven by a simple observation: aging itself is the leading risk factor for most of the diseases we fear most (cancer, Alzheimer's, heart disease, diabetes).
The field was transformed in 2013 by a landmark paper — "The Hallmarks of Aging" by Lopez-Otin and colleagues — which identified the key cellular and molecular processes that drive aging. This gave researchers a unified framework and target list. An updated version in 2023 added new hallmarks, reflecting how rapidly the science is moving.
Key Researchers to Know
David Sinclair (Harvard): Popularized NMN, NAD+, and sirtuins research. His "information theory of aging" proposes that aging is fundamentally a loss of epigenetic information, not irreversible damage. Author of "Lifespan."
Peter Attia (Stanford-trained, now independent): Focuses on the "Medicine 3.0" approach — preventing the chronic diseases of aging before they occur. Strong emphasis on exercise as medicine, metabolic health, and evidence-based supplementation. Author of "Outlive."
Morgan Levine (Yale/Altos Labs): Developer of biological age clocks including PhenoAge and GrimAge. Leading researcher on epigenetic aging and what accelerates or decelerates it.
Aubrey de Grey (SENS Research Foundation): More radical approach — advocates for engineering approaches to "repair" the damage of aging rather than slow its accumulation. Influential but controversial.
What Actually Works Now
Exercise: The most evidence-backed longevity intervention. Zone 2 cardio + strength training reduces all-cause mortality more reliably than any drug or supplement. Non-negotiable.
Diet: Mediterranean diet pattern associated with 20–30% reduction in all-cause mortality in multiple large studies. Time-restricted eating (16:8) shows promising epigenetic aging effects.
Sleep: 7–9 hours consistently. Chronic short sleep is as dangerous as smoking for long-term health outcomes.
Supplements: D3/K2, magnesium, omega-3, and creatine have the strongest evidence as foundation. NMN, berberine, and spermidine are promising additions for those with the basics covered.
Rapamycin and Metformin (prescription): Most interesting pharmaceutical longevity interventions, both with strong mechanistic and some human evidence. Require medical supervision — not OTC options.
Where the Field is Heading
The most exciting near-term developments: senolytics (drugs that clear "zombie" senescent cells), partial reprogramming (resetting epigenetic age), and personalized longevity protocols based on individual epigenetic data. Companies like Altos Labs, Calico (Google), and Unity Biotechnology are pouring billions into these approaches.
The honest timeline: meaningful life extension drugs in clinical trials within 5–10 years; broader access within 15–20 years. What you do now with lifestyle and supplements still matters enormously — you want to be healthy enough to benefit from whatever comes next.
Start your longevity protocol today
Our evidence-based supplement recommendations — from foundations to advanced longevity compounds.
See Best Longevity Supplements →